AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11967245 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 43
Study 11967245 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 43
Study 9527182 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally diluted tepid blood cardioplegia (Mini group, n = 19)
Number of subjects: 37
Study 9527182 — intervention group
Group type: COMPARATOR
Intervention: Standard 4:1 diluted tepid blood cardioplegia (4:1 group, n = 18)
Number of subjects: 37
Study 7884615 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine therapy (20 mg/kg/day)
Number of subjects: 30
Study 7884615 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine therapy (20 mg/kg/day) with prednisolone
Number of subjects: 30
Study 7884615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 1978619 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (24 micrograms)
Number of subjects: 12
Study 1978619 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol (200 micrograms)
Number of subjects: 12
Study 1978619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6996472 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose
Number of subjects: 11
Study 6996472 — intervention group
Group type: EXPERIMENTAL
Intervention: Potato
Number of subjects: 11
Study 6996472 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice
Number of subjects: 11
Study 6996472 — intervention group
Group type: EXPERIMENTAL
Intervention: Bread
Number of subjects: 11
Study 6996472 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn
Number of subjects: 11
Study 6996472 — intervention group
Group type: EXPERIMENTAL
Intervention: All carbohydrate loads
Number of subjects: 11
Study 31712337 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Toolkit and the Back Book
Number of subjects: 0
Study 31712337 — intervention group
Group type: COMPARATOR
Intervention: Back Book only
Number of subjects: 0
Study 28744857 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative intravenous methylprednisolone 125 mg
Number of subjects: 70
Study 26374625 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 10 mg maintenance dose
Number of subjects: 3400
Study 26374625 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 5 mg maintenance dose
Number of subjects: 3400
Study 26374625 — intervention group
Group type: COMPARATOR
Intervention: Biostable-polymer PtCr-EES
Number of subjects: 3400
Study 26374625 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable-polymer BP-BES
Number of subjects: 3400
Study 23568561 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kVp protocol
Number of subjects: 100
Study 23568561 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kVp protocol with optimized display preset
Number of subjects: 100
Study 23568561 — intervention group
Group type: COMPARATOR
Intervention: 120 kVp protocol
Number of subjects: 100
Study 20012051 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation combined with continuous passive motion (CPM‐ES)
Number of subjects: 40
Study 20012051 — intervention group
Group type: COMPARATOR
Intervention: Isometric exercise
Number of subjects: 40
Study 19736157 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin and provisional GPIIb/IIIa inhibition
Number of subjects: 32
Study 19736157 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) and mandatory GPIIb/IIIa
Number of subjects: 32
Study 19736157 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 32
Study 17339385 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation
Number of subjects: 192
Study 17339385 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 192
Study 16802195 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4 counts <50 cells/microl
Number of subjects: 1017
Study 16802195 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms (CES-D >/= 23)
Number of subjects: 1017
Study 16802195 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, gender, education, and source of income adjustments
Number of subjects: 1017
Study 12757072 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 600 mg/day
Number of subjects: 35
Study 12757072 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole 600 mg/day
Number of subjects: 35
Study 10969219 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (1.2 to 2 g bolus)
Number of subjects: 859
Study 10969219 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 859
Study 8889757 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated altitude at 3,500 m during exercise
Number of subjects: 7
Study 8889757 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated altitude at moderate levels (> 2,500 m) during exercise
Number of subjects: 7
Study 8889757 — intervention group
Group type: COMPARATOR
Intervention: Exercise at all altitude levels
Number of subjects: 7
Study 8889757 — intervention group
Group type: EXPERIMENTAL
Intervention: Altitude effects at 3,500 m
Number of subjects: 7
Study 1857478 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (300 mg/day)
Number of subjects: 0
Study 1857478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7036280 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-drug treatment (CMFVP)
Number of subjects: 0
Study 7036280 — intervention group
Group type: COMPARATOR
Intervention: Three-drug treatment (CMF)
Number of subjects: 0
Study 31759464 — intervention group
Group type: EXPERIMENTAL
Intervention: PATHS curriculum implementation
Number of subjects: 28
Study 31759464 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive attitudes towards PATHS
Number of subjects: 28
Study 31759464 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive culture for social-emotional learning (SEL)
Number of subjects: 28
Study 31759464 — intervention group
Group type: EXPERIMENTAL
Intervention: Early career teachers
Number of subjects: 28
Study 28276794 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ribavirin (33 mg/kg followed by 16 mg/kg every 6 hours for 4 days and 8 mg/kg every 8 hours for 3 days) plus standard therapy
Number of subjects: 73
Study 28276794 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 73
Study 25925875 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (80-120 mg/day)
Number of subjects: 0
Study 25925875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23664681 — intervention group
Group type: EXPERIMENTAL
Intervention: a-tDCS with 12 cm² electrode size
Number of subjects: 12
Study 23664681 — intervention group
Group type: EXPERIMENTAL
Intervention: a-tDCS with 24 cm² electrode size
Number of subjects: 12
Study 23664681 — intervention group
Group type: EXPERIMENTAL
Intervention: a-tDCS with 35 cm² electrode size
Number of subjects: 12
Study 21349928 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol, 150 μg once daily
Number of subjects: 415
Study 21349928 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol, 300 μg once daily
Number of subjects: 415
Study 21349928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 415
Study 19660021 — intervention group
Group type: EXPERIMENTAL
Intervention: CP-690,550 15 mg BID (CP15)
Number of subjects: 60
Study 19660021 — intervention group
Group type: EXPERIMENTAL
Intervention: CP-690,550 30 mg BID (CP30)
Number of subjects: 60
Study 19660021 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 60
Study 17898337 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine at a dose of 50 mg at bedtime
Number of subjects: 1
Study 17898337 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowering the dosages of antiparkinsonian medications
Number of subjects: 1
Study 17898337 — intervention group
Group type: EXPERIMENTAL
Intervention: Restoration of dopamine agonist dosage
Number of subjects: 1
Study 15172869 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-absorbing polyglactin 910
Number of subjects: 1361
Study 11499564 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 1-g i.v. for three days at months 1, 3, and 5, plus oral prednisone (0.5 mg/kg every other day for six months)
Number of subjects: 86
Study 11499564 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 86
Study 11360502 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g intravenous ceftriaxone once a day (group A)
Number of subjects: 197
Study 11360502 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g intravenous cefotaxime three times a day (group B)
Number of subjects: 197
Study 11360502 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.25 g intravenous cefuroxime three times a day (group C)
Number of subjects: 197
Study 7869314 — intervention group
Group type: EXPERIMENTAL
Intervention: sulfasalazine treatment
Number of subjects: 84
Study 7869314 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 84
Study 3365292 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg zinc/day
Number of subjects: 47
Study 30289392 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) administered at 1 mg/kg via subcutaneous injection twice a day between days 1 and 7
Number of subjects: 100
Study 30289392 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 100
Study 30289392 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 100
Study 27666953 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly designed work uniform
Number of subjects: 568
Study 27666953 — intervention group
Group type: COMPARATOR
Intervention: Commercially available trade uniform
Number of subjects: 568
Study 25810045 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional botulinum toxin type A (BTA) 5 IU/cm(3) repeated every 8 weeks for three sessions (group B)
Number of subjects: 24
Study 25810045 — intervention group
Group type: COMPARATOR
Intervention: Intralesional corticosteroid therapy repeated every 4 weeks for six sessions (group A)
Number of subjects: 24
Study 23677811 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg ESL (to-be-marketed formulation)
Number of subjects: 40
Study 23677811 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg ESL (to-be-marketed formulation)
Number of subjects: 40
Study 23677811 — intervention group
Group type: COMPARATOR
Intervention: 400 mg ESL (marketed formulation)
Number of subjects: 40
Study 23677811 — intervention group
Group type: COMPARATOR
Intervention: 800 mg ESL (marketed formulation)
Number of subjects: 40
Study 21367950 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg Fe + folic acid (IFA)
Number of subjects: 1268
Study 21367950 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg Fe + folic acid + 13 micronutrients (UNIMMAP)
Number of subjects: 1268
Study 21367950 — intervention group
Group type: EXPERIMENTAL
Intervention: UNIMMAP
Number of subjects: 1268
Study 21367950 — intervention group
Group type: EXPERIMENTAL
Intervention: IFA
Number of subjects: 1268
Study 21367950 — intervention group
Group type: COMPARATOR
Intervention: UNIMMAP or IFA
Number of subjects: 1268
Study 21367950 — intervention group
Group type: COMPARATOR
Intervention: Micronutrient intake (both groups)
Number of subjects: 1268
Study 21367950 — intervention group
Group type: COMPARATOR
Intervention: Micronutrient intake
Number of subjects: 1268
Study 19271829 — intervention group
Group type: COMPARATOR
Intervention: No-contact control group
Number of subjects: 690
Study 17671061 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (20 ppm, weaned to 2 ppm)
Number of subjects: 99
Study 17671061 — intervention group
Group type: COMPARATOR
Intervention: Placebo gas
Number of subjects: 99
Study 15493566 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous, low-level, topical heat wrap therapy
Number of subjects: 344
Study 15493566 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (1000 mg)
Number of subjects: 344
Study 12112107 — intervention group
Group type: EXPERIMENTAL
Intervention: Deprenyl (10mg/day)
Number of subjects: 368
Study 12112107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 368
Study 10438356 — intervention group
Group type: EXPERIMENTAL
Intervention: valacyclovir
Number of subjects: 310
Study 10438356 — intervention group
Group type: COMPARATOR
Intervention: acyclovir
Number of subjects: 310
Study 8675970 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 1
Study 8675970 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone after desensitization
Number of subjects: 1
Study 2196306 — intervention group
Group type: EXPERIMENTAL
Intervention: High-expectancy condition
Number of subjects: 63
Study 346315 — intervention group
Group type: EXPERIMENTAL
Intervention: Halcinonide solution (0.1%)
Number of subjects: 27
Study 346315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 31257044 — intervention group
Group type: EXPERIMENTAL
Intervention: Buzzy (MMJ Labs, Atlanta, GA)
Number of subjects: 160
Study 31257044 — intervention group
Group type: EXPERIMENTAL
Intervention: ShotBlocker (Bionix Development Corporation, Toledo, OH)
Number of subjects: 160
Study 31257044 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble-blowing
Number of subjects: 160
Study 31257044 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study 28619310 — intervention group
Group type: EXPERIMENTAL
Intervention: 20, 1-hour dancing classes over 10 weeks (n=15)
Number of subjects: 27
Study 28619310 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group (n=12)
Number of subjects: 27
Study 26379122 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy with support to taper and/or discontinue antidepressant medication (MBCT-TS)
Number of subjects: 424
Study 26379122 — intervention group
Group type: COMPARATOR
Intervention: Maintenance antidepressant medication (m-ADM)
Number of subjects: 424
Study 24089294 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0
Study 24089294 — intervention group
Group type: COMPARATOR
Intervention: Generic Clopidogrel
Number of subjects: 0
Study 21872277 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublobar resection (SR)
Number of subjects: 222
Study 21872277 — intervention group
Group type: COMPARATOR
Intervention: Segmental resection
Number of subjects: 222
Study 19217669 — intervention group
Group type: EXPERIMENTAL
Intervention: Various treatment protocols
Number of subjects: 162
Study 17353577 — intervention group
Group type: EXPERIMENTAL
Intervention: High phytate (HP) diet (P:Zn molar ratio = 23) for 9 days
Number of subjects: 17
Study 17353577 — intervention group
Group type: COMPARATOR
Intervention: Lower phytate (LP) diet (P:Zn molar ratio = 10) for 9 days after a wash-out period
Number of subjects: 17
Study 15179168 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose ATP (225 mg)
Number of subjects: 27
Study 15179168 — intervention group
Group type: COMPARATOR
Intervention: Low dose ATP (150 mg)
Number of subjects: 27
Study 15179168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 11837981 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.4 g/d of highly concentrated very long chain n‐3 PUFA after CABG
Number of subjects: 610
Study 11837981 — intervention group
Group type: COMPARATOR
Intervention: Very long chain n‐3 PUFA 5.1-8.0 g/d after PTCA
Number of subjects: 610
Study 11837981 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.4-5.7 g/d of very long chain n‐3 PUFA after heart transplantation
Number of subjects: 610
Study 11837981 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.1 g/d of very long chain n‐3 PUFA
Number of subjects: 610
Study 9113569 — intervention group
Group type: EXPERIMENTAL
Intervention: Photorefractive keratectomy (PRK)
Number of subjects: 31
Study 9113569 — intervention group
Group type: COMPARATOR
Intervention: Control (normal eyes of myopic patients)
Number of subjects: 31
Study 8246581 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic perfusion
Number of subjects: 30
Study 8246581 — intervention group
Group type: COMPARATOR
Intervention: Hypothermic perfusion
Number of subjects: 30
Study 3818036 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerua lanata extract (200 ml of 50 g/L)
Number of subjects: 0
Study 3818036 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerua lanata extract (100 g/L)
Number of subjects: 0
Study 3818036 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 0
Study 3818036 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 0
Study 3818036 — intervention group
Group type: COMPARATOR
Intervention: Coriander (Coriandrum sativum) extract (control)
Number of subjects: 0
Study 3818036 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw flowers of Aerua lanata
Number of subjects: 0
Study 30814121 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy with computer-aided diagnosis (AI system)
Number of subjects: 1058
Study 30814121 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 1058
Study 28682892 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided femoral nerve block with ropivacaine 0.2% and 0.3mg buprenorphine
Number of subjects: 0
Study 28682892 — intervention group
Group type: COMPARATOR
Intervention: Femoral nerve block with ropivacaine 0.2% only
Number of subjects: 0
Study 28682892 — intervention group
Group type: COMPARATOR
Intervention: 0.3mg buprenorphine subcutaneously
Number of subjects: 0
Study 26244949 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral paracetamol (15mg/kg/dose 6 hourly for 7 days)
Number of subjects: 77
Study 26244949 — intervention group
Group type: COMPARATOR
Intervention: Intravenous indomethacin (0.2 mg/kg/dose once daily for 3 days)
Number of subjects: 77
Study 26244949 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 77
Study 23766638 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted errorless learning-based memory training program (CELP)
Number of subjects: 19
Study 23766638 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-led errorless learning program (TELP)
Number of subjects: 19
Study 23766638 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 19
Study 21340182 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity ultrasound therapy (LIUST)
Number of subjects: 26
Study 21340182 — intervention group
Group type: COMPARATOR
Intervention: Control-placebo (CP)
Number of subjects: 26
Study 18359179 — intervention group
Group type: EXPERIMENTAL
Intervention: CT angiograms using a medium-smooth kernel (B30s)
Number of subjects: 20
Study 18359179 — intervention group
Group type: EXPERIMENTAL
Intervention: CT angiograms using a sharp kernel (B60s)
Number of subjects: 20
Study 18359179 — intervention group
Group type: COMPARATOR
Intervention: Digital subtraction angiography (DSA)
Number of subjects: 20
Study 17568241 — intervention group
Group type: COMPARATOR
Intervention: Increased mean low-density lipoprotein (LDL) diameter
Number of subjects: 6105
Study 17568241 — intervention group
Group type: COMPARATOR
Intervention: Increased large LDL particle concentration
Number of subjects: 6105
Study 17568241 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) increase of 10 mmHg
Number of subjects: 6105
Study 17568241 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean LDL diameter increase of 1 nm
Number of subjects: 6105
Study 17568241 — intervention group
Group type: EXPERIMENTAL
Intervention: Large LDL particle concentration increase of 100 nmol/l
Number of subjects: 6105
Study 17568241 — intervention group
Group type: COMPARATOR
Intervention: C-reactive protein (CRP) levels
Number of subjects: 6105
Study 17568241 — intervention group
Group type: COMPARATOR
Intervention: Soluble vascular cell adhesion molecule 1 (sVCAM-1) levels
Number of subjects: 6105
Study 17568241 — intervention group
Group type: COMPARATOR
Intervention: Homocysteine levels
Number of subjects: 6105
Study 17568241 — intervention group
Group type: COMPARATOR
Intervention: Amino-terminal-pro-B-type natriuretic peptide (NT-proBNP) levels
Number of subjects: 6105
Study 17568241 — intervention group
Group type: COMPARATOR
Intervention: Renin levels
Number of subjects: 6105
Study 14597482 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 55
Study 14597482 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 55
Study 11824893 — intervention group
Group type: EXPERIMENTAL
Intervention: MVCarbo regimen (mitomycin C, vinblastine, and carboplatin)
Number of subjects: 43
Study 10332320 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 39
Study 10332320 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam plus ibuprofen
Number of subjects: 39
Study 10332320 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 39
Study 10332320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 8335426 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg administered twice daily with meals
Number of subjects: 24
Study 8335426 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 20 mg administered twice daily one hour before meals
Number of subjects: 24
Study 2868254 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium
Number of subjects: 273
Study 2868254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 273
Study 2508737 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (5‐fluorouracil, adriamycin and mitomycin C)
Number of subjects: 436
Study 2508737 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy
Number of subjects: 436
Study 2508737 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 436
Study 29791925 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific instrumentation (PSI)
Number of subjects: 22
Study 29791925 — intervention group
Group type: COMPARATOR
Intervention: Conventional instrumentation
Number of subjects: 22
Study 28323950 — intervention group
Group type: COMPARATOR
Intervention: Light-intensity walking interruptions (LW)
Number of subjects: 21